Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac manifestation of metabolic syndrome. NAFLD is strongly linked to CAD and hepatic steatosis is an independent risk factor for CAD and cardiac morta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open Gastroenterol
Asıl Yazarlar: Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2016
Konular:
Hepatology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964159/
https://ncbi.nlm.nih.gov/pubmed/27493762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2016-000096
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller